Table 2 Genes associated with breast cancer risk at the Bonferroni-corrected significant level of 0.05

From: Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes

Breast cancer subtypea

Gene

Cytoband

Nearest index SNPb

Z score

P value

Exp-TWAS

   Overall

CTD-3080P12.3

5p15.33

rs2853669

4.7

3.2 × 10−6

   ER-Negd

EN1

2q14.2

rs76664032c

−5.7

1.6 × 10−8

LINC01956

2q14.2

rs76664032c

−5.4

5.3 × 10−8

   TNBCd

EN1

2q14.2

rs76664032c

−5.8

6.9 × 10−9

LINC01956

2q14.2

rs76664032c

−5.6

2.5 × 10−8

APA-WAS

   Overall

TET2

4q24

rs62331150

−4.4

1.2 × 10−5

   ER-Neg

TET2

4q24

rs62331150

−4.9

1.2 × 10−6

spTWAS

   Overall

BRD9

5p15.33

rs2853669

−4.7

2.3 × 10−6

NUP210L

1q21.3

/

−4.7

3.0 × 10−6

   ER-Neg

BRD9

5p15.33

rs2853669

−5.2

2.2 × 10−7

   TNBC

BRD9

5p15.33

rs2853669

−4.8

1.8 × 10−6

  1. P values were derived from the Z score tests (two-sided). Statistical significant threshold for multiple comparison adjustment is defined as P < 5.0 × 10−6 for gene expression TWAS of 9982 tests (0.05/9982), P < 1.5 × 10−5 for APA-WAS of 3309 tests (0.05/3309), and P < 4.3 × 10−6 for spTWAS of 11,426 tests (0.05/11,426) using Bonferroni correction.
  2. aER-Pos estrogen receptor (ER)-positive, ER-Neg ER-negative, TNBC triple-negative breast cancer, TWAS transcriptome-wide association study, Exp-TWAS gene expression TWAS, APA-WAS alternative polyadenylation (APA)-wide association study, spTWAS splicing TWAS.
  3. bWithin ± 500 Kb region.
  4. cThis index SNP (rs76664032) was identified in our recent GWAS conducted among AA female participants.
  5. dSuggestive associations were found for genes CTD-3080P12.3 (P = 1.3 × 10−5) with ER-negative breast cancer risk and MRPL34 (P = 9.2 × 10−6) with TNBC risk at the p value near the significant threshold after Bonferroni correction.